phospho c jun (Cell Signaling Technology Inc)
96
Structured Review
Cell Signaling Technology Inc
phospho c jun
Phospho C Jun, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 575 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/Phospho-c-Jun+(Ser73)+XP+Rabbit+mAb/10__1038_slash_s41598___026___73232___0-52-36-38
Average 96 stars, based on 575 article reviews
Phospho C Jun, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 575 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/Phospho-c-Jun+(Ser73)+XP+Rabbit+mAb/10__1038_slash_s41598___026___73232___0-52-36-38
Average 96 stars, based on 575 article reviews
phospho c jun - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
other:Article Title: Supplemental Materials A Small Molecular Bidentate-Binding Dual Inhibitor Probe of the LRRK2 and JNK3 Kinases Article Snippet: The concentration of protein in the supernatant was quantified by BCA analysis using the Pierce kit protocol. Article Title: A Plant-Based Diet Alleviates Molecular Pulmonary Abnormalities in Hypertension Article Snippet: Article Title: Gynostemma pentaphyllum Hydrodistillate and Damulin B Prevent UVB-Induced Photoaging In Vitro and In Vivo via ROS Suppression and Restoration of MAPK/AP-1 and TGF-β/Smad Signaling. Article Snippet: Antibodies against p44/42 MAPK (Erk1/2)(4695S), phosphop44/42 MAPK (Erk1/2) (4376S), SAPK/JNK(9252S), phosphoSAPK/JNK(4668S), p38 MAPK (9212S), phospho-p38 MAPK (9211S), c-Jun (9165S), Phospho-c-Jun (3270S), c-Fos (2250S), phospho-c-Fos (5348S), TIMP1 (8946S), TIMP2 (5738S), SMAD2/3 (8685S), phospho-SMAD2/3 (8828S), MMP-1 (54376S), MMP3 (14351S), TGF- β (3711S), SOD2 (13141S), and Incubation:Article Title: Pyrazole pyrimidine derivative and uses thereof Article Snippet: .. Blots were incubated with the following antibodies: Phospho-IRAK1 (Thr209), (A1074, AssayBiothechnology; 1/1,000), Phospho-IKKα/β (Ser176/180) (16A6, Cell Signaling; 1/1,000), IKKα (2682, cell signaling; 1/1,1000), IKKβ (2370, cell signaling; 1/1,1000), Article Title: Xaliproden improves diabetic kidney disease through JNK-mediated renal tubular protection Article Snippet: Diabetic kidney disease (DKD) is a major diabetic complication and the primary global cause of end-stage renal disease.. Hyperglycemia triggers multiple pathological signaling pathways and ultimately leads to structural alterations and functional decline in the kidney.. Xaliproden is a 5-HT1A receptor agonist originally developed for its neuroprotective effects; however, its impacts on renal disease remain unknown. Article Title: Docetaxel treatment upregulates estrogen receptor expression in triple negative breast cancer cells via activating arachidonic acid pathway Article Snippet: .. The membranes were blocked with 3% bovine serum albumin (BSA) to prevent nonspecific binding and incubated with primary antibodies: anti-Estrogen Receptor alpha antibody (ab75635, Abcam), Cleaved caspase 3 (9661, Cell Signaling Technology, CST), c-Jun (9165, CST), Bioprocessing:Article Title: Molecular Basis of Surfactin-Induced Macrophage Modulation and Its Implications in Medication-Related Osteonecrosis of the Jaw Pathogenesis Article Snippet: Polyclonal antibodies for SAPK/JNK, phospho-SAPK/JNK (Thr183/Tyr185), p38 MAPK, phospho-p38 MAPK (Thr180/Tyr182), STAT1, and phospho-STAT1 (Tyr701) were purchased from Cell Signaling Technology (Beverly, MA, USA). .. Monoclonal antibodies for p44/42 MAPK (Erk1/2; 137F5), phospho-p44/42 MAPK (Erk1/2; Thr202/Tyr204) (D13.14.4E), IκBα (L35A5), c-Jun (60A8), Nonspecific Binding:Article Title: Docetaxel treatment upregulates estrogen receptor expression in triple negative breast cancer cells via activating arachidonic acid pathway Article Snippet: .. The membranes were blocked with 3% bovine serum albumin (BSA) to prevent nonspecific binding and incubated with primary antibodies: anti-Estrogen Receptor alpha antibody (ab75635, Abcam), Cleaved caspase 3 (9661, Cell Signaling Technology, CST), c-Jun (9165, CST), Cell-Signaling:Article Title: Docetaxel treatment upregulates estrogen receptor expression in triple negative breast cancer cells via activating arachidonic acid pathway Article Snippet: .. The membranes were blocked with 3% bovine serum albumin (BSA) to prevent nonspecific binding and incubated with primary antibodies: anti-Estrogen Receptor alpha antibody (ab75635, Abcam), Cleaved caspase 3 (9661, Cell Signaling Technology, CST), c-Jun (9165, CST), |